More info on the EACTS annual edition
Learn MoreWhere to find us at EACTS Booth
See Our location
|
|
|
|||
---|---|---|---|---|---|
11:00 – 13:00 | Aortic Valve | Hall D | Add to Calendar | ||
Endoscopic sutureless aortic valve replacement (Live 3D)
-M.Solinas (Italy) Minimally-invasive aortic annulus enlargement and valve replacement (live 3D) - L. Conradi (Germany) |
|||||
13:30 – 15:15 | Aorta and Coronary | Hall D | Add to Calendar | ||
15:40 – 18:00 | Atrioventricular Valves | Hall D | Add to Calendar | ||
Endoscopic mitral valve replacement using a new prosthesis and automatic suturing device (Live 3D)
- A. Pitsis (Greece) |
|
|
|
|||
---|---|---|---|---|---|
08:30 – 09:30 | President's Choice | Hall D | Add to Calendar | ||
Statin treatment after surgical aortic valve replacement due to aortic stenosis is associated with better long-term outcome
– E. Pan (USA) More information Extracted from the 2023 EACTS program, focusing on heart valve disease and devices. All abstracts have been extracted from the EACTS website |
|||||
10:00 – 11:00 | Fixing tricuspid regurgitation:work in progress! | Hall G1 | Add to Calendar | ||
Risk assessment in tricuspid surgery: the TRISCORE- J.Dreyfus
Skilful omission of ring annuloplasty: you can dare in pulmonary thromboendarterectomy – M. Castella (Spain) Techniques for Tricuspid Valve Repair: do subannular approaches really help G. Färber- (Germany) |
|||||
11:15 – 12:00 | Honoured Guest | Hall D | Add to Calendar | ||
13:45 – 14:45 | Supporting the economics of patient management and procedures in cardiac surgery through science | 0.31/0.32 | Add to Calendar | ||
Improving the quality of care and efficiency in cardiac surgery through an early discharge algorithm– E. Zias (USA)
|
|||||
13:45 – 14:45 | Artificial intelligence in procedural planning and performance in transcatheter techniques | Hall G1 | Add to Calendar | ||
Can AI speed up and evaluate echo data in transcatheter procedures-G. Strange (Australia)
|
|||||
13:45 – 14:45 | Improving CABG outcome in women: a call to action | Hall E2(Interactive) | Add to Calendar | ||
The need for surgical trials in women; the case for ROMA: Women- M. Gaudino (USA)
|
|||||
13:45 – 14:45 | Update on tissue valve durability | Hall D | Add to Calendar | ||
Experimental evidence to increase prosthetic valve durability - P. Akhyari
What do real world data show us ? Insights from the Indure Registry- Lauger Is improved haemodynamic a way to prolong durability?- R. Sádaba (Pamplona, Spain) Is long term durability maintained when using sutureless valves– B. Meuris |
|||||
15:00 – 16:00 | Mitral valve interventions, challenges in 2023 | Hall K2 | Add to Calendar | ||
17:30 – 18:30 | Late Breaking Science 3 | Hall E2(Interactive) | Add to Calendar | ||
Five-year Clinical and Echocardiographic Results of New Generation Bioprosthetic valves: Real World data from a multicenter registry – A.Francica (Italy)
Gender-based analysis of patient outcomes and safety of surgical aortic valve replacement – A.Zierer (Austria) Subannular Repair for Secondary Mitral Regurgitation with restricted systolic leaflet Motion (type IIIb): 2-year results from REFORM-MR registry– E. Girdauskas (Germany) |
|
|
|
|||
---|---|---|---|---|---|
08:30 – 09:30 | Science behind aortic valve repair | Hall G2 | Add to Calendar | ||
Outcome differences depending on bicuspid valve phenotype
- L. de Kerchove (Belgium)
|
|||||
10:00 – 11:00 | Aortic Valve repair | Hall G1 | Add to Calendar | ||
Yacoub versus Bentall procedure in a nationwide propensity-matched long-term comparison- J. Gofus
More information Twenty-five Years Experience of Isolated BAV Repair - T. Ehrlich More information Extracted from the 2023 EACTS program, focusing on heart valve disease and devices. All abstracts have been extracted from the EACTS website |
|||||
11:15 – 12:00 | Presidential Address | Hall D | Add to Calendar | ||
The Death of Dogma is the Birth of Reality (Immanuel Kant)- P. Perier
|
|||||
16:15 – 17:15 | Unsolved issues in transcatheter valve procedures | Hall E1 | Add to Calendar | ||
Five-year outcomes after transcatheter versus surgical aortic valve replacement in low-risk patients- V. Lodo (Italy)
More information Gender differences in transcatheter aortic valve implantation- V. Lodo More information Extracted from the 2023 EACTS program, focusing on heart valve disease and devices. All abstracts have been extracted from the EACTS website |
|||||
16:15 – 17:15 | AV replacement | Hall F1 (Interactive) | Add to Calendar | ||
Mechanical or biological aortic valve replacement in hemodialysis patients:
a propensity score matching analysis with long-term results from the TriNetX global network- B. Del Forno More information Sutureless prostheses inside degenerated stentless aortic valves and bioroots – clinical outcomes from a multi-centre experience- M. Silaschi (Germany) More information Structural valve degeneration after ten-years from aortic valve replacement with pericardial prosthesis in non-elderly adults - A. Francica More information Impact of explanted valve type on outcomes in re-operative aortic valve replacements - P. Narayan More information Extracted from the 2023 EACTS program, focusing on heart valve disease and devices. All abstracts have been extracted from the EACTS website |
|
|
|
|||
---|---|---|---|---|---|
08:00 – 09:00 | Aortic Valve replacement | Hall K2 | Add to Calendar | ||
5-year results from a prospective, single-arm European trial on decellularized allografts for aortic valve replacement-The ARISE Study - S. Sarikouch
More information Long-Term Outcomes of the Ross Procedure Versus Bioprosthetic Versus Mechanical Aortic Valve Replacement: A Network Meta-Analysis - J. Velasco More information Hemodynamic Function of Contemporary Surgical Aortic Valves 1 Year Postimplant- R. Klautz More information Extracted from the 2023 EACTS program, focusing on heart valve disease and devices. All abstracts have been extracted from the EACTS website |
|||||
10:30– 12:00 | Trial Update | Hall D | Add to Calendar |
|
|
|
||
---|---|---|---|---|
08:30 – 10:00 | New options for imaging in planning and performance of transcatheter treatment, including remote proctoring | Amber 1 & 2 | ||
10:30 – 12:00 | Clinical trial updates | Auditorium |
Meet Us On Our Booth